IMATINIB (CHEMOTINIB) TABLET – TREATMENT FOR BLOOD CANCER
Tyrosine kinase inhibitors are a family of drugs that includes Chemotinib 400mg Tablet. It is used to treat gastrointestinal stromal tumors as well as two types of blood cancer: chronic myeloid leukemia and acute lymphocytic leukemia.
To achieve the best benefit, Chemotinib 400mg Tablet should be taken with food at the same time each day. As long as your doctor recommends it, you should keep taking it. Depending on your needs and how you respond to treatment, the length of treatment varies. It can have potentially dangerous negative effects if taken improperly or in excess.
USES OF IMATINIB (CHEMOTINIB) TABLET
- Blood cancer
WORKS OF IMATINIB (CHEMOTINIB) TABLET
Chemotinib 400mg Tablets are a cancer preventative drug. Bcr-Abl tyrosine kinase is a protein enzyme that is in charge of the aberrant proliferation of cancer cells. In bar-all positive cells, this medication suppresses proliferation and causes apoptosis (planned cell death) (cancer cells). This is how the progression of cancer is slowed or stopped.
SIDE EFFECTS OF IMATINIB (CHEMOTINIB) TABLET
- Edema (swelling)
- Muscle cramp
- Musculoskeletal (bone, muscle, or joint) pain
WARNING & PRECAUTIONS
Chemotinib 400mg Tablet adverse effects may impair your ability to operate a motor vehicle.
Patients with kidney illness should use chemotinib 400mg Tablets with caution. Chemotinib 400mg Tablet dosage may need to be changed. Please speak with your physician.
Patients with severe liver disease should use chemotinib 400 mg tablets with caution. Chemotinib 400mg Tablet dosage may need to be changed. Please speak with your physician.
Fedelty Health Care is an Imatinib third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.